Overall, we revealed that neutralizing anti-IFN-γ autoAbs were detectable in the serum of 7.9% of COVID-19 patients, even higher in severe/critical patients in the Asian population, up to 18.0%. The gene discussed is IFNG; the disease is COVID-19.